Medtronic Plc Stock Fundamentals
| MDTC34 Stock | BRL 244.06 3.07 1.27% |
Medtronic plc fundamentals help investors to digest information that contributes to Medtronic Plc's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic Plc stock.
Medtronic |
Medtronic plc Company Return On Asset Analysis
Medtronic Plc's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medtronic Plc Return On Asset | 0.0422 |
Most of Medtronic Plc's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medtronic plc has a Return On Asset of 0.0422. This is 100.48% lower than that of the Healthcare sector and 100.23% lower than that of the Medical Devices industry. The return on asset for all Brazil stocks is 130.14% lower than that of the firm.
Medtronic plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medtronic Plc's current stock value. Our valuation model uses many indicators to compare Medtronic Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medtronic Plc competition to find correlations between indicators driving Medtronic Plc's intrinsic value. More Info.Medtronic plc is regarded fourth in return on equity category among its peers. It is regarded fifth in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medtronic plc is roughly 1.97 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medtronic Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medtronic Plc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Medtronic Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic Plc's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic Plc could also be used in its relative valuation, which is a method of valuing Medtronic Plc by comparing valuation metrics of similar companies.Medtronic Plc is regarded fourth in return on asset category among its peers.
Medtronic Fundamentals
| Return On Equity | 0.0833 | |||
| Return On Asset | 0.0422 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 625.84 B | |||
| Shares Outstanding | 2.66 B | |||
| Price To Earning | 52.06 X | |||
| Price To Book | 2.03 X | |||
| Price To Sales | 18.03 X | |||
| Revenue | 31.69 B | |||
| Gross Profit | 21.71 B | |||
| EBITDA | 8.78 B | |||
| Net Income | 5.04 B | |||
| Cash And Equivalents | 10.6 B | |||
| Cash Per Share | 3.94 X | |||
| Total Debt | 20.32 B | |||
| Debt To Equity | 0.50 % | |||
| Current Ratio | 2.89 X | |||
| Book Value Per Share | 19.50 X | |||
| Cash Flow From Operations | 7.35 B | |||
| Earnings Per Share | 8.13 X | |||
| Price To Earnings To Growth | 3.05 X | |||
| Number Of Employees | 95 K | |||
| Beta | 0.73 | |||
| Market Capitalization | 589.18 B | |||
| Total Asset | 90.98 B | |||
| Z Score | 17.4 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 90.98 B | |||
| Last Dividend Paid | 2.62 |
About Medtronic Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 90000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Medtronic Stock refer to our How to Trade Medtronic Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.